Paeds Vivas · neurology-neurodisability-and-neuromuscular
Infantile spasms and developmental epileptic encephalopathy — branching viva
Branching viva on infantile spasms and the developmental and epileptic encephalopathies: applying the West syndrome triad and the ILAE 2022 IESS definition, interpreting hypsarrhythmia, building the aetiology workup with tuberous sclerosis as the leading identifiable cause, explaining the immature-cortex and CRH stress-axis mechanism, and defending the first-line vigabatrin-versus-hormonal decision driven by the TSC status.
On this page
Study tools
Target exams
Opening framework
My framework has four layers. First, the diagnosis: this six-month-old with clustered flexor spasms, developmental regression and a chaotic EEG has West syndrome, now called infantile epileptic spasms syndrome, defined by the ILAE 2022 position statement. Second, the mechanism: an immature cortex driven into a hypersynchronous network by a lesion or genetic disturbance, with the CRH stress axis explaining why ACTH and corticosteroids work. Third, the management: a sleep EEG and MRI confirm the syndrome, and first-line therapy turns on whether the cause is tuberous sclerosis — vigabatrin if it is, hormonal therapy if it is not. Fourth, the clock: every week of delay worsens developmental outcome, so this is a neurodevelopmental emergency. [1] [4]
References11ShowHide
- [1]Zuberi SM, Wirrell E, Yozawitz E, et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia, 2022.PMID 35503712
- [2]O'Callaghan FJK, Edwards SW, Alber FD, et al. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial. Lancet Child Adolesc Health, 2018.PMID 30236380
- [3]Go CY, Mackay MT, Weiss SK, et al. Evidence-based guideline update: medical treatment of infantile spasms. Neurology, 2012.PMID 22689735
- [4]Wilmshurst JM, Gaillard WD, Vinayan KP, et al. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia, 2015.PMID 26122601
- [5]Pellock JM, Hrachovy R, Shinnar S, et al. Infantile spasms: a U.S. consensus report. Epilepsia, 2010.PMID 20608959
- [6]Elterman RD, Shields WD, Mansfield KA, et al. Randomized trial of vigabatrin in patients with infantile spasms. Neurology, 2001.PMID 11673582
- [7]Stafstrom CE. Infantile epileptic spasms syndrome: mechanisms and therapeutic approaches. Neurotherapeutics, 2026.PMID 41419420
- [8]Biswas A, Yossofzai O, Vincent A, et al. Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis. Expert Rev Neurother, 2020.PMID 33078964
- [9]Wheless JW, Gibson PA, Rosbeck KL, et al. Infantile spasms (West syndrome): update and resources for pediatricians and providers to share with parents. BMC Pediatr, 2012.PMID 22830456
- [10]Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol, 2013.PMID 24053982
- [11]D'Alonzo R, Rigante D, Mencaroni E, Esposito S. West Syndrome: a review and guide for paediatricians. Clin Drug Investig, 2018.PMID 29086890